Capital World Investors’s Quince Therapeutics QNCX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-2,494,010
| Closed | -$15.4M | – | 584 |
|
2022
Q1 | $15.4M | Sell |
2,494,010
-7,872
| -0.3% | -$48.7K | ﹤0.01% | 505 |
|
2021
Q4 | $31.6M | Sell |
2,501,882
-985,113
| -28% | -$12.4M | 0.01% | 495 |
|
2021
Q3 | $320M | Buy |
3,486,995
+159,593
| +5% | +$14.6M | 0.05% | 257 |
|
2021
Q2 | $176M | Buy |
3,327,402
+2,373
| +0.1% | +$126K | 0.03% | 324 |
|
2021
Q1 | $120M | Buy |
3,325,029
+714,792
| +27% | +$25.8M | 0.02% | 345 |
|
2020
Q4 | $72.5M | Buy |
2,610,237
+4,903
| +0.2% | +$136K | 0.01% | 374 |
|
2020
Q3 | $130M | Hold |
2,605,334
| – | – | 0.03% | 310 |
|
2020
Q2 | $121M | Buy |
2,605,334
+1,861,934
| +250% | +$86.2M | 0.03% | 292 |
|
2020
Q1 | $33.9M | Buy |
743,400
+171,073
| +30% | +$7.8M | 0.01% | 358 |
|
2019
Q4 | $32.1M | Buy |
572,327
+313,945
| +122% | +$17.6M | 0.01% | 382 |
|
2019
Q3 | $6.44M | Buy |
+258,382
| New | +$6.44M | ﹤0.01% | 487 |
|